CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- DEFR14A Other DEFR14A
- D Other Notice of Sales of Unregistered Securities
- CT ORDER Other Confidential Order
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- 10KSB/A Other 10KSB/A
- EFFECT Other Notice of Effectiveness
- 10KSB Other 10KSB
- REGDEX Other REGDEX
- 10QSB Other 10QSB
- DEFA14A Proxy Proxy Materials
- 10QSB Other 10QSB
- 8-A12G Other 8-A12G
- 10QSB Other 10QSB
- EFFECT Other Notice of Effectiveness
- SB-2/A Other SB-2/A
- EFFECT Other Notice of Effectiveness
Page 8 of 13 · 258 filings